Format

Send to

Choose Destination
Nat Biotechnol. 2017 Jan;35(1):69-74. doi: 10.1038/nbt.3749. Epub 2016 Dec 12.

Influence of donor age on induced pluripotent stem cells.

Author information

1
Department of Molecular and Cellular Neuroscience, The Scripps Research Institute, La Jolla, California, USA.
2
The Scripps Translational Science Institute, Scripps Health and The Scripps Research Institute, La Jolla, California, USA.

Abstract

Induced pluripotent stem cells (iPSCs) are being pursued as a source of cells for autologous therapies, many of which will be aimed at aged patients. To explore the impact of age on iPSC quality, we produced iPSCs from blood cells of 16 donors aged 21-100. We find that iPSCs from older donors retain an epigenetic signature of age, which can be reduced through passaging. Clonal expansion via reprogramming also enables the discovery of somatic mutations present in individual donor cells, which are missed by bulk sequencing methods. We show that exomic mutations in iPSCs increase linearly with age, and all iPSC lines analyzed carry at least one gene-disrupting mutation, several of which have been associated with cancer or dysfunction. Unexpectedly, elderly donors (>90 yrs) harbor fewer mutations than predicted, likely due to a contracted blood progenitor pool. These studies establish that donor age is associated with an increased risk of abnormalities in iPSCs and will inform clinical development of reprogramming technology.

PMID:
27941802
PMCID:
PMC5505172
DOI:
10.1038/nbt.3749
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center